Employed in standard Chinese, Ayurvedic, and Thai medication. Conolidine could signify the start of a completely new period of Serious pain administration. Now it is being investigated for its outcomes over the atypical chemokine receptor (ACK3). In a rat design, it was found that a competitor molecule binding to ACKR3 resulted in inhibition of ACK